Global Celiac Disease Clinical Trials Review Market Growth and Trend to 2015 Radiant Insights, Inc
Summary Radiant Insights's clinical trial report, "Celiac Disease Global Clinical Trials Review, H1, 2015" provides data on the Celiac Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Celiac Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Celiac Disease. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Radiant Insights's team of industry experts. View Full Report with TOC @ http://www.radiantinsights.com/research/celiac-disease-global-clinical-trials-review-h1-2015 Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Reason to Buy - Understand the dynamics of a particular indication in a condensed manner - Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more - Obtain discontinued trial listing for trials across the globe - Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Summary
Radiant Insights's clinical trial report, "Celiac Disease Global Clinical Trials Review, H1, 2015" provides data on the Celiac Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Celiac Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Celiac Disease. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Radiant Insights's team of industry experts.
View Full Report with TOC @ http://www.radiantinsights.com/research/celiac-disease-global-clinical-trials-review-h1-2015
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reason to Buy
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by ImmusanT, <strong>Inc</strong>., <strong>2015</strong>*<br />
30<br />
<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Alvine<br />
Pharmaceuticals, <strong>Inc</strong>., <strong>2015</strong>* 31<br />
<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Royal DSM N.V.,<br />
<strong>2015</strong>* 32<br />
<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Parexel International<br />
Corporation, <strong>2015</strong>* 33<br />
<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by BioLineRx, Ltd., <strong>2015</strong>*<br />
34<br />
<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Meda AB, <strong>2015</strong>* 35<br />
<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by InVentiv Group<br />
Holdings, <strong>Inc</strong>., <strong>2015</strong>* 36<br />
<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by ChemoCentryx, <strong>Inc</strong>.,<br />
<strong>2015</strong>* 37<br />
View Full Report with TOC @ http://www.radiantinsights.com/research/celiac-disease-globalclinical-trials-review-h1-<strong>2015</strong><br />
<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Calypso Biotech SA,<br />
<strong>2015</strong>* 38<br />
<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by All India Institute of<br />
Medical Sciences, <strong>2015</strong>* 39<br />
<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Beth Israel Deaconess<br />
Medical Center, <strong>Inc</strong>., <strong>2015</strong>* 40<br />
<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Maastricht University<br />
Medical Center, <strong>2015</strong>* 41<br />
<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Shaare Zedek Medical<br />
Center, <strong>2015</strong>* 42<br />
<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Azienda Ospedaliera<br />
Spedali Civili di Brescia, <strong>2015</strong>* 43<br />
<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Columbia University,<br />
<strong>2015</strong>* 44<br />
<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Dr. C. Bonorino<br />
Udaondo Gastroenterology Hospital, <strong>2015</strong>* 45<br />
<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Heim Pal Children's<br />
Hospital, <strong>2015</strong>* 46
Change language